Cargando…

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma

Kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) are the most common RCC types. RCC has high immune infiltration levels, and immunotherapy is currently one of the most promising treatments for RCC. Collagen triple helix repeat containing 1 (CTHRC1) is an extr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fenfang, Shen, Dexin, Xiong, Yaoyi, Cheng, Songtao, Xu, Huimin, Wang, Gang, Qian, Kaiyu, Ju, Lingao, Zhang, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898899/
https://www.ncbi.nlm.nih.gov/pubmed/33628726
http://dx.doi.org/10.3389/fonc.2020.570819
_version_ 1783653961210789888
author Zhou, Fenfang
Shen, Dexin
Xiong, Yaoyi
Cheng, Songtao
Xu, Huimin
Wang, Gang
Qian, Kaiyu
Ju, Lingao
Zhang, Xinhua
author_facet Zhou, Fenfang
Shen, Dexin
Xiong, Yaoyi
Cheng, Songtao
Xu, Huimin
Wang, Gang
Qian, Kaiyu
Ju, Lingao
Zhang, Xinhua
author_sort Zhou, Fenfang
collection PubMed
description Kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) are the most common RCC types. RCC has high immune infiltration levels, and immunotherapy is currently one of the most promising treatments for RCC. Collagen triple helix repeat containing 1 (CTHRC1) is an extracellular matrix protein that regulates tumor invasion and modulates the tumor microenvironment. However, the association of CTHRC1 with the prognosis and tumor-infiltrating lymphocytes of KIRP and KIRC has not been reported. We examined the CTHRC1 expression differences in multiple tumor tissues and normal tissues via exploring TIMER, Oncomine, and UALCAN databases. Then, we searched the Kaplan-Meier plotter database to evaluate the correlation of CTHRC1 mRNA level with clinical outcomes. Subsequently, the TIMER platform and TISIDB website were chosen to assess the correlation of CTHRC1 with tumor immune cell infiltration level. We further explored the causes of aberrant CTHRC1 expression in tumorigenesis. We found that CTHRC1 level was significantly elevated in KIRP and KIRC tissues relative to normal tissues. CTHRC1 expression associates with tumor stage, histology, lymph node metastasis, and poor clinical prognosis in KIRP. The CTHRC1 level correlates to tumor grade, stage, nodal metastasis, and worse survival prognosis. Additionally, CTHRC1 is positively related to different tumor-infiltrating immune cells in KIRP and KIRC. Moreover, CTHRC1 was closely correlated with the gene markers of diverse immune cells. Also, high CTHRC1 expression predicted a worse prognosis in KIRP and KIRC based on immune cells. Copy number variations (CNV) and DNA methylation might contribute to the abnormal upregulation of CTHRC1 in KIRP and KIRC. In conclusion, CTHRC1 can serve as a biomarker to predict the prognosis and immune infiltration in KIRP and KIRC.
format Online
Article
Text
id pubmed-7898899
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78988992021-02-23 CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma Zhou, Fenfang Shen, Dexin Xiong, Yaoyi Cheng, Songtao Xu, Huimin Wang, Gang Qian, Kaiyu Ju, Lingao Zhang, Xinhua Front Oncol Oncology Kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) are the most common RCC types. RCC has high immune infiltration levels, and immunotherapy is currently one of the most promising treatments for RCC. Collagen triple helix repeat containing 1 (CTHRC1) is an extracellular matrix protein that regulates tumor invasion and modulates the tumor microenvironment. However, the association of CTHRC1 with the prognosis and tumor-infiltrating lymphocytes of KIRP and KIRC has not been reported. We examined the CTHRC1 expression differences in multiple tumor tissues and normal tissues via exploring TIMER, Oncomine, and UALCAN databases. Then, we searched the Kaplan-Meier plotter database to evaluate the correlation of CTHRC1 mRNA level with clinical outcomes. Subsequently, the TIMER platform and TISIDB website were chosen to assess the correlation of CTHRC1 with tumor immune cell infiltration level. We further explored the causes of aberrant CTHRC1 expression in tumorigenesis. We found that CTHRC1 level was significantly elevated in KIRP and KIRC tissues relative to normal tissues. CTHRC1 expression associates with tumor stage, histology, lymph node metastasis, and poor clinical prognosis in KIRP. The CTHRC1 level correlates to tumor grade, stage, nodal metastasis, and worse survival prognosis. Additionally, CTHRC1 is positively related to different tumor-infiltrating immune cells in KIRP and KIRC. Moreover, CTHRC1 was closely correlated with the gene markers of diverse immune cells. Also, high CTHRC1 expression predicted a worse prognosis in KIRP and KIRC based on immune cells. Copy number variations (CNV) and DNA methylation might contribute to the abnormal upregulation of CTHRC1 in KIRP and KIRC. In conclusion, CTHRC1 can serve as a biomarker to predict the prognosis and immune infiltration in KIRP and KIRC. Frontiers Media S.A. 2021-02-08 /pmc/articles/PMC7898899/ /pubmed/33628726 http://dx.doi.org/10.3389/fonc.2020.570819 Text en Copyright © 2021 Zhou, Shen, Xiong, Cheng, Xu, Wang, Qian, Ju and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Fenfang
Shen, Dexin
Xiong, Yaoyi
Cheng, Songtao
Xu, Huimin
Wang, Gang
Qian, Kaiyu
Ju, Lingao
Zhang, Xinhua
CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
title CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
title_full CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
title_fullStr CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
title_full_unstemmed CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
title_short CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
title_sort cthrc1 is a prognostic biomarker and correlated with immune infiltrates in kidney renal papillary cell carcinoma and kidney renal clear cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898899/
https://www.ncbi.nlm.nih.gov/pubmed/33628726
http://dx.doi.org/10.3389/fonc.2020.570819
work_keys_str_mv AT zhoufenfang cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT shendexin cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT xiongyaoyi cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT chengsongtao cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT xuhuimin cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT wanggang cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT qiankaiyu cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT julingao cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma
AT zhangxinhua cthrc1isaprognosticbiomarkerandcorrelatedwithimmuneinfiltratesinkidneyrenalpapillarycellcarcinomaandkidneyrenalclearcellcarcinoma